Patent Assignment
Reel/Frame 010625/0993
Assignment of Assignor's Interest
Recorded: 2000-03-23
Pages: 2
Assignors
SHAN, JACQUELINE J.
Executed: 2000-03-20
WU, XI-CHEN
Executed: 2000-03-20
PANG, PETER K.T.
Executed: 2000-03-13
LING, LEI
Executed: 2000-03-21
Assignee
CV TECHNOLOGIES, INC.
SUITE 308, 8625-112 STREET, EDMONTON, ALBERTA, T6G 1, CANADA
Covered Property
(1)
Hypericin and Hypericum Extract: Specific T-Type Calcium Channel Blocker, and Their Use as T-Type Calcium Channel Targeted Therapeutics
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 27, 2006
From: CV TECHNOLOGIES, INC.
To: FX LIVE SCIENCES INTERNATIONAL GMBH
Reel/Frame 018323/0483 →
Assignment of Assignor's Interest
Oct 23, 2006
From: CV TECHNOLOGIES, INC.
To: FX LIFE SCIENCES INTERNATIONAL GMBH
Reel/Frame 018420/0325 →
Assignment of Assignor's Interest
Dec 23, 2008
From: FX LIFE SCIENCES INTERNATIONAL GMBH
To: FX LIFE SCIENCES AG
Reel/Frame 022012/0925 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →